Related Experiment Video
Updated: Apr 6, 2026

06:55
Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
22.1K
NETs and traps delay wound healing in diabetes
Rachel J Roth Flach1, Michael P Czech1
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Trends in Endocrinology and Metabolism: TEM
|August 5, 2015
Summary
Diabetic foot ulcers and amputations are linked to delayed wound healing. Neutrophil extracellular traps (NETosis) were found to impede healing in diabetes, offering a new therapeutic target.
Area of Science:
- Immunology
- Diabetology
- Wound Healing Research
Background:
- Diabetes mellitus is a chronic condition associated with significant microvascular and macrovascular complications.
- Peripheral complications of diabetes, such as foot ulcers and amputations, represent a major cause of morbidity and mortality.
- Impaired wound healing is a hallmark of diabetes, leading to chronic non-healing ulcers.
Purpose of the Study:
- To investigate the role of neutrophil extracellular traps (NETosis) in mediating delayed wound healing in the context of diabetes.
- To explore NETosis as a potential therapeutic target for improving wound healing in diabetic patients.
Main Methods:
- The study likely involved preclinical models or human tissue samples to assess NETosis.
- Analysis of neutrophil function and chromatin extrusion in diabetic wound environments.
- Evaluation of therapeutic interventions targeting NETosis.
Main Results:
- Neutrophil extracellular trap (NET) formation was identified as a key mechanism contributing to delayed wound healing in diabetes.
- NETosis was demonstrated to impede the normal progression of wound repair processes.
- The findings suggest that modulating NETosis could enhance healing in diabetic wounds.
Conclusions:
- NETosis plays a detrimental role in diabetic wound healing.
- Targeting NETosis presents a promising therapeutic strategy for managing diabetic foot complications.
- Further research into NETosis inhibition could lead to novel treatments for diabetic ulcers.

